Sen. Tom Harkin led members of a Senate Appropriations subcommittee in a hearing Wednesday on the economic impact of Alzheimer’s disease, as Congress works with the medical community to realize the Obama administration’s ambitious goal of curing the ailment by 2025.
The subcommittee questioned leaders from the National Institutes of Health and the National Institute of Aging, along with other experts. Other witnesses included a comedian and Alzheimer’s activist Seth Rogen, who brought a little star power — and levity — to the proceedings which were, needless to say, pretty grim.
Though Alzheimer’s is the sixth-leading cause of death in the United States, it isn’t as commonly discussed or as well funded as some of the other diseases, several researchers testified. Worse, it is the only one of the top 10 deadliest diseases in the nation for which there is no treatment to slow its progress. There is no cure and it is always fatal.
And the disease is growing rapidly, as are the costs associated with caring for patients. Care for those suffering from Alzheimer’s and other types of dementia is expected to grow from $203 billion last year to $1.2 trillion by 2050, according to Harkin’s office. Medicare and Medicaid costs associated with the disease could grow by as much as 500 percent over the same period.
As such, appropriators included major funding for medical research in their fiscal year 2014 spending bill, which passed both chambers in January. The bill includes an $80 million increase, compared with 2012, in funding for Alzheimer’s prevention and research at the National Institute on Aging, which is part of NIH.
Sen. Barbara Mikulski, D-Md., who chairs the Appropriations Committee, noted in her questioning that her own father died of Alzheimer’s. She asked them what Congress could do to help find a cure.
“I think we are not at the moment limited by ideas. We’re not limited by scientific opportunities, we’re not limited by talent, we’re unfortunately limited by resources to move this enterprise forward at the pace that it could take,” NIH Director Francis Collins told the senator. He pointed out that the funding for Alzheimer’s research is minimal poor that just one out of every six scientists with a promising research idea will actually get the money for it.
That got Rogen — who peppered the story of his mother-in-law’s early diagnosis at the age of 55 with jokes — going. He warned that without better funding, researchers with ideas for an Alzheimer’s cure might choose to study something “sexier,” like heart disease. The lack of funding shows “people of my generation,” Rogen said, “that it’s just not that high a priority on the national level.”
Former Rep. Dennis Moore, D-Kansas, also called for more research funding at the hearing. Moore, who left Congress in 2011, was diagnosed with Alzheimer’s disease himself shortly thereafter and has since become an advocate. He noted that NIH spending for Alzheimer’s research has lagged (a point that also found its way into a debate on this season’s House of Cards, as the disease begins to gain more prominence). “The direct cost of Alzheimer’s and related dementia is greater than any other condition in the United States, including heart disease and cancer,” Moore said, citing a study published by the New England Journal of Medicine.
But Collins and others pointed to a positive sign for researchers: the Accelerating Medicines Partnership, which was formed by NIH earlier this month to combat Alzheimer’s and other diseases. The venture represents an “unprecedented” level of cooperation between 10 pharmaceutical companies — including giants like Pfizer, GlaxoSmithKline, and Johnson & Johnson — as well as several nonprofit groups, NIH, and the Food and Drug Administration.
The 10 companies have kicked in a total of $61.9 million, with NIH offering another $67.6 million, to research and produce Alzheimer’s medications within the next five years. Alzheimer’s was one of the few diseases that was big enough to bring all 10 usually competing companies — and their cash — to the table, Collins said.
The project is part of a larger federal goal to find a cure for the disease by 2025. Before Congress boosted its funding in January, NIH had planned to spend about $562 million on Alzheimer’s research this year, compared to nearly $10 billion for cancer and almost $2 billion for heart disease.
Still, National Institute on Aging Director Richard Hodes said the goal is attainable. “Ambitious as it is, we have no choice,” he said, noting the growing “urgency” of the issue as the American population ages.
What We're Following See More »
"The Senate standstill over a stopgap spending bill appeared headed toward a resolution on Friday night. Senators who were holding up the measure said votes are expected later in the evening. West Virginia Democrat Joe Manchin had raised objections to the continuing resolution because it did not include a full year's extension of retired coal miners' health benefits," but Manchin "said he and other coal state Democrats agreed with Senate Democratic leaders during a caucus meeting Thursday that they would not block the continuing resolution, but rather use the shutdown threat as a way to highlight the health care and pension needs of the miners."
Donald Trump transition team announced Friday afternoon that top supporter Rudy Giuliani has taken himself out of the running to be in Trump's cabinet, though CNN previously reported that it was Trump who informed the former New York City mayor that he would not be receiving a slot. While the field had seemingly been narrowed last week, it appears to be wide open once again, with ExxonMobil CEO Rex Tillerson the current favorite.
Given the Senate's inaction on the continuing budget resolution (so far), the White House "said it has begun to work with agencies to prepare for the possibility of a large swath of the federal workforce being furloughed without pay beginning at midnight." Even if a shutdown occurs, however, "Senate procedures will allow the chamber to approve the CR with only a handful of Democrats in support by Sunday morning. Of the roughly 900,000 federal employees who were subject to furloughs in agencies’ most recent calculations, most would not be materially impacted as they do not work on weekends."
The House has completed it's business for 2016 by passing a spending bill which will keep the government funded through April 28. The final vote tally was 326-96. The bill's standing in the Senate is a bit tenuous at the moment, as a trio of Democratic Senators have pledged to block the bill unless coal miners get a permanent extension on retirement and health benefits. The government runs out of money on Friday night.